A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
Part of paid clinical trials in Miami, Florida.
- Sponsor
- Intuitive Surgical
- Study ID
- NCT06879912
- Status
- Recruiting
Conditions
- Colorectal
- Gynecologic
- Hernia, Inguinal
- Hernia, Ventral
- Partial Nephrectomy
- Thoracic
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to understand the utility of force feedback instruments in surgeries that are done using the da Vinci 5 robot.
Key Dates
- Start date
- May 22, 2025
- Status verified
- Oct 2025
- Primary completion
- Aug 31, 2026
- Completion
- Aug 31, 2026
Study Design
- Enrollment
- 200 participants (estimated)
Primary Outcome Measure
To assess the force imparted on the tissue by force feedback instruments. [ Time Frame: Intra-operative ]
Central Contacts
- Smruthi Srinivasa Murthy682-552-6131
- Manish Bharara
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Miami | Miami | Florida | 33136 | Elena Cortizas Mark Gonzalgo (PRINCIPAL_INVESTIGATOR) |
| Northeast Georgia Medical Center, Inc | Gainesville | Georgia | 30501 | Holly Jones, PhD Chad Copper (PRINCIPAL_INVESTIGATOR) |
| Northwestern Memorial Healthcare | Chicago | Illinois | 60611 | Nisha Palanisamy Samuel Kim (PRINCIPAL_INVESTIGATOR) |
| Ohio State University | Columbus | Ohio | 43210 | Robert Merritt (PRINCIPAL_INVESTIGATOR) |
| St. David's Healthcare | Austin | Texas | 78758 | Thiru Lakshman (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
Related Studies
- GORE® ENFORM Biomaterial Product StudyRecruiting · W.L.Gore & Associates · San Diego, California
- Ventral or Inguinal Hernia, Robotically Repaired With OviTex MeshRecruiting · Tela Bio Inc · Mobile, Alabama
- Mesh Removal Versus No Mesh Removal for Chronic Groin Pain After Inguinal Hernia RepairRecruiting · David Krpata · Cleveland, Ohio
- A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal AdenocarcinomaRecruiting · M.D. Anderson Cancer Center · Houston, Texas